FIELD: biotechnology.
SUBSTANCE: invention relates to a method of obtaining a population of dopaminergic neurons from the substantia nigra of mice. This method involves obtaining substantia nigra tissue from mice, incubating the resulting tissue with the GBR-BP dye, dissociating the stained tissue to obtain a cell suspension with partially dissociated tissue, incubating the resulting cell suspension with partially dissociated tissue together with DRAQ5 and GBR-BP dyes, repeated dissociation stained cell suspension with partially dissociated tissue to obtain a stained cell suspension and isolating DRAQ5+/GBR-BP+ cells from the resulting stained cell suspension.
EFFECT: invention is used to increase the efficiency of obtaining a population of dopaminergic neurons.
4 cl, 8 dwg, 1 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC DRUG FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND ITS USE | 2019 |
|
RU2799454C2 |
PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
RECOVERED MYELOID-LIKE CELL POPULATIONS AND METHOD OF TREATING WITH USING SUCH POPULATIONS | 2007 |
|
RU2473686C2 |
METHOD OF OBTAINING POPULATION OF NEURAL DIFFERENTIATION INDUCED STROMAL CELLS OF FAT TISSUE | 2008 |
|
RU2396345C1 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DEGENERATIVE NEUROLOGICAL DISORDERS WHICH COMPRISES, AS AN ACTIVE INGREDIENT, A MIXED ROOT EXTRACT OF THE TREE PEONY ROOT, THE ROOT OF DAHURIC ANGELICA AND THE ROOT OF THOROWAX OR ITS FRACTION | 2015 |
|
RU2668135C1 |
PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURONS OR NEURODEGENERATION | 2011 |
|
RU2722018C2 |
TRANSPLANTATION OF NERVE CELLS FOR TREATMENT OF NEURODEGENERATIVE STATES | 2005 |
|
RU2434636C2 |
PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE | 2012 |
|
RU2618412C2 |
ISOLATED POPULATIONS OF MYELOID-LIKE CELLS OF BONE MARROW AND METHODS OF TREATMENT WITH THEM | 2006 |
|
RU2418856C2 |
Authors
Dates
2024-01-17—Published
2022-04-11—Filed